Mergers & Acquisitions ·
Waldencast plc completed the sale of its Obagi Medical dermatological skincare and aesthetics business to Bridgepoint…
WALDWWaldencast plc
Waldencast plc completed the sale of its Obagi Medical dermatological skincare and aesthetics business to Bridgepoint on July 30, 2026. The transaction is valued at up to $460 million, comprising a fixed vendor note of $10 million, an adjustable vendor note of $20 million, and contingent earnout payments of up to $64 million based on revenue milestones through December 2027. Proceeds were used to repay all outstanding senior term loan facility debt. Founders Michel Brousset and Hind Sebti, along with CFO Manuel Manfredi, transitioned to lead Obagi Medical. Felipe Dutra was appointed Executive Chairman and will serve as principal executive and financial officer. Waldencast plc operates in the beauty industry, focusing on the global growth of its Milk Makeup brand.